EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Do we need dosimetry for the optimization of theranostics in CNS tumors?

Francesco Cicone iD, Silvano Gnesin, Giulia Santo, Caroline Stokke, Mirco Bartolomei, Giuseppe Lucio Cascini, Giuseppe Minniti, Giovanni Paganelli, Antoine Verger, Marta Cremonesi

Neuro-Oncology · 2024

DOI: 10.1093/neuonc/noae200 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuro-Oncology, 2024. Verfasst von Francesco Cicone und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Unit, Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, Catanzaro, Italy. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Radiopharmaceuticals, Radiometry. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Union Next-GenerationEU NRRP-Research Projects of National Interest, Italian Ministry for University and Research, European Union Next-GenerationEU NRRP—Research Projects of National Interest.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiopharmaceutical theranostic treatments have grown exponentially worldwide, and internal dosimetry has attracted attention and resources. Despite some similarities with chemotherapy, radiopharmaceutical treatments are essentially radiotherapy treatments, as the release of radiation into tissues is the determinant of the observed clinical effects. Therefore, absorbed dose calculations are key to explaining dose-effect correlations and individualizing radiopharmaceutical treatments. The present article introduces the basic principles of internal dosimetry and provides an overview of available loco-regional and systemic radiopharmaceutical treatments for central nervous system (CNS) tumors. The specific characteristics of dosimetry as applied to these treatments are highlighted, along with their limitations and most relevant results. Dosimetry is performed with higher precision and better reproducibility than in the past, and dosimetric data should be systematically collected, as treatment planning and verification may help exploit the full potential of theranostic of CNS tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System NeoplasmsRadiopharmaceuticalsRadiometryHumansTheranostic NanomedicineRadiotherapy DosagePrecision Medicine

Stichwörter der Autor:innen

brain tumorsinternal dosimetrymolecular radiotherapyradionuclide therapytheranostic

Substanzen

Radiopharmaceuticals

Autor:innen und Institutionen

  • Nuclear Medicine Unit, Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.
  • Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Department of Physics, University of Oslo, Oslo, Norway.
  • Department of Diagnostic Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  • Nuclear Medicine Unit, Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.
  • IRCCS Neuromed, Pozzilli (IS), Italy.

ORCID-Profile: Francesco Cicone

Förderung

  • European Union Next-GenerationEU NRRP-Research Projects of National Interest
  • Italian Ministry for University and Research
  • European Union Next-GenerationEU NRRP—Research Projects of National Interest

Zitieren

APA

Cicone, F., Gnesin, S., Santo, G., Stokke, C., Bartolomei, M., Cascini, G. L., Minniti, G., Paganelli, G., Verger, A., & Cremonesi, M. (2024). Do we need dosimetry for the optimization of theranostics in CNS tumors?. Neuro-Oncology. https://doi.org/10.1093/neuonc/noae200

Vancouver

Cicone F, Gnesin S, Santo G, Stokke C, Bartolomei M, Cascini GL, et al. Do we need dosimetry for the optimization of theranostics in CNS tumors?. Neuro-Oncology. 2024. doi:10.1093/neuonc/noae200

BibTeX
@article{Cicone2024,
  author = {Cicone, Francesco and Gnesin, Silvano and Santo, Giulia and Stokke, Caroline and Bartolomei, Mirco and Cascini, Giuseppe Lucio and Minniti, Giuseppe and Paganelli, Giovanni and Verger, Antoine and Cremonesi, Marta},
  title = {Do we need dosimetry for the optimization of theranostics in CNS tumors?},
  journal = {Neuro-Oncology},
  year = {2024},
  doi = {10.1093/neuonc/noae200}
}
Kostenlos starten →